Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Assets Average (2018 - 2025)

Historic Assets Average for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $292.6 million.

  • Neurogene's Assets Average rose 7012.94% to $292.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.6 million, marking a year-over-year increase of 7012.94%. This contributed to the annual value of $279.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Neurogene's Assets Average is $292.6 million, which was up 7012.94% from $306.3 million recorded in Q2 2025.
  • Neurogene's 5-year Assets Average high stood at $325.5 million for Q1 2025, and its period low was $91.8 million during Q3 2023.
  • For the 3-year period, Neurogene's Assets Average averaged around $204.3 million, with its median value being $187.6 million (2024).
  • Examining YoY changes over the last 5 years, Neurogene's Assets Average showed a top increase of 9493.05% in 2024 and a maximum decrease of 3053.97% in 2024.
  • Over the past 3 years, Neurogene's Assets Average (Quarter) stood at $156.1 million in 2023, then soared by 60.13% to $249.9 million in 2024, then grew by 17.06% to $292.6 million in 2025.
  • Its Assets Average stands at $292.6 million for Q3 2025, versus $306.3 million for Q2 2025 and $325.5 million for Q1 2025.